Corporate and regulatory developments over the Christmas period

Corporate and regulatory developments over the Christmas period

Submitted by admin on January 2, 2020 - 11:39pm
Source: 
EP Vantage
News Tags: 
Astellas
M&A
Qiagen
AstraZeneca
Bausch Health
BeiGene
Celyad
Immunomedics
Merck
Merck KGaA
Ono Pharmaceutical
Pfizer
Pharming
Xyphos Biosciences
Headline: 
Corporate and regulatory developments over the Christmas period
snippet: 

On the corporate front Astellas continued to buy, while Qiagen decided that it was not, after all, up for sale.

Do Not Allow Advertisers to Use My Personal information